Primorigen Biosciences gets grant for stem cell work
Excerpted from Wisconsin State Journal
By Judy Newman
Primorigen Biosciences, Madison, has received a $1.2 million Phase 2 Small Business Innovation Research grant from the National Institutes of Health.
The latest grant comes on the heels of two smaller, Phase 1 SBIR grants from the National Institutes of Health totaling nearly $673,000, received over the past several months. One involves improving the ability of adult stem cells to convert to neural cells, in a project partnership with the Medical College of Wisconsin. The other involves a new type of cell culturing technology designed to improve the function of stem cell-derived liver cells.